In detail, miR-125b transported in AML-derived exosomes targets apoptotic regulators such as BAK1 and CBFβ, suppressing p53-driven apoptosis and promoting leukemic blast survival and proliferation. This evidence concerns the gene TP53 and acute myeloid leukemia.